MEGAN MASON: Open Payments
NPI 1245825553 · VERO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,367 in 105 payments from 33 companies in 2025. Trend: 2023 $2,933 · 2024 $3,036 · 2025 $2,367
Food & beverage: $2,367
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $331 |
| AstraZeneca Pharmaceuticals LP | 11 | $266 |
| ABBVIE INC. | 9 | $203 |
| Novartis Pharmaceuticals Corporation | 8 | $156 |
| ARRAY BIOPHARMA INC | 5 | $109 |
| PFIZER INC. | 6 | $95 |
| Gilead Sciences, Inc. | 4 | $95 |
| Dendreon Pharmaceuticals LLC | 3 | $91 |
| Daiichi Sankyo Inc. | 3 | $85 |
| BeOne Medicines USA, Inc. | 3 | $84 |
Products named: TECVAYLI, Enhertu, VENCLEXTA, KISQALI, Trodelvy, PROVENGE, RYBREVANT, Lenvima.
Industry payments across FL — which companies pay providers there.
